Skip to content

A retrospective cohort study to evaluate the effectiveness of green channel application for gastrointestinal bleeding treatment

A retrospective cohort study to evaluate the effectiveness of green channel application for gastrointestinal bleeding treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092952
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding

Interventions

Green channel MDT treatment group (using the green channel MDT procedure for rescue):None
Traditional treatment group (Traditional emergency treatment, not using the green channel for rescue):None

Sponsors

Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age greater than 18 years old; (2) A clear diagnosis of acute gastrointestinal bleeding in accordance with the current guidelines, "Guidelines for the diagnosis and treatment of lower gastrointestinal bleeding (2020)", "Expert consensus on the emergency diagnosis and treatment of acute upper gastrointestinal bleeding (2020)" and "Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding (Hangzhou, 2018)"; (3) Hospitalized to receive full treatment.

Exclusion criteria

Exclusion criteria: (1) Those who die within 48h of hospitalization time; (2) Those with comorbid severe cardiovascular and cerebrovascular diseases and malignant tumor diseases; (3) Those with inaccurate clinical data and major relevant outcome indicators (including including age, gender, BMI, comorbidities, blood pressure, heart rate, Helicobacter pylori infection status, urea nitrogen, predicted bleeding volume, whether variceal bleeding, site of bleeding, therapeutic interventions, number of endoscopic interventions, blood transfusion, use of hemostatic drugs, use of PPI medications, time of portal microscopy, length of hospitalization, hospitalization cost, whether death and rebleeding during hospitalization) were missing.

Design outcomes

Primary

MeasureTime frame
Time between emergency room registration and formal treatment (surgery) ;venous hemorrhage;

Secondary

MeasureTime frame
hospitalized recurrent hemorrhage;mortality;Duration of hospitalization;hospitalization cost;Estimated Bleeding Volume;volume of blood transfused;Use of hemostatic drugs;PPI medication use;

Countries

China

Contacts

Public ContactChaoqiang Fan

Second Affiliated Hospital of Army Medical University

fcqxhkwjs@126.com+86 159 2278 1214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026